Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 4:2019:1101-1110.
eCollection 2019.

Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study

Qian Li  1 , Zhe He  2 , Yi Guo  1 , Hansi Zhang  1 , Thomas J George  1 , William Hogan  1 , Neil Charness  2 , Jiang Bian  1
Affiliations

Assessing the Validity of a a priori Patient-Trial Generalizability Score using Real-world Data from a Large Clinical Data Research Network: A Colorectal Cancer Clinical Trial Case Study

Qian Li et al. AMIA Annu Symp Proc. .

Abstract

Existing trials had not taken enough consideration of their population representativeness, which can lower the effectiveness when the treatment is applied in real-world clinical practice. We analyzed the eligibility criteria of Bevacizumab colorectal cancer treatment trials, assessed their a priori generalizability, and examined how it affects patient outcomes when applied in real-world clinical settings. To do so, we extracted patient-level data from a large collection of electronic health records (EHRs) from the OneFlorida consortium. We built a zero-inflated negative binomial model using a composite patient-trial generalizability (cPTG) score to predict patients' clinical outcomes (i.e., number of serious adverse events, [SAEs]). Our study results provide a body of evidence that 1) the cPTG scores can predict patient outcomes; and 2) patients who are more similar to the study population in the trials that were used to develop the treatment will have a significantly lower possibility to experience serious adverse events.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Populations in clinical trials.
Figure 2.
Figure 2.
Overall study design and selection of study populations.
Figure 3.
Figure 3.
Selection window for serious adverse events related to treating colorectal cancer with Bevacizumab
See this image and copyright information in PMC

References

    1. From the NIH Director: The Importance of Clinical Trials | NIH MedlinePlus the Magazine. Accessed March. 2019;4 https://medlineplus.gov/magazine/issues/summer11/articles/summer11pg2-3.....
    1. Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet Lond Engl. 2005;365(9453):82–93. doi:10.1016/S0140-6736(04)17670-8. - PubMed
    1. Sedgwick P. External and internal validity in clinical trials. BMJ. 2012;344(feb16 1):e1004–e1004. doi:10.1136/bmj.e1004.
    1. Schoenmaker N, Van Gool WA. The age gap between patients in clinical studies and in the general population: a pitfall for dementia research. Lancet Neurol. 2004;3(10):627–630. doi:10.1016/S1474-4422(04)00884-1. - PubMed
    1. Sardar MR, Badri M, Prince CT, Seltzer J, Kowey PR. Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines. JAMA Intern Med. 2014;174(11):4758. 1868-1870. doi:10.1001/jamainternmed 2014. - PubMed

Publication types

LinkOut - more resources